The identification of dendritic cells in 1973 fundamentally altered the scientific understanding of how the human body initiates adaptive immunity. Working within the laboratory of Zanvil A. Cohn at The Rockefeller University, Ralph Steinman isolated a distinct cell type that acted as a bridge between innate defense mechanisms and the long-term memory of the immune system.
Academic Foundations and Early Training
Born in Montreal in 1943, Ralph Steinman spent his youth in Sherbrooke, Quebec, where his family operated a clothing store. He returned to Montreal to pursue undergraduate studies at McGill University. Following this, he transitioned to Harvard Medical School, earning his M.D. with magna cum laude honors in 1968. His clinical training included an internship and residency at Massachusetts General Hospital, providing the medical framework for his later career in research.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Discovery of Dendritic Cells
At The Rockefeller University, Steinman investigated the components necessary for initiating antibody responses in tissue culture. His research identified that accessory cells, which were previously grouped with macrophages, displayed unique morphological traits. Unlike macrophages, these new cells—named dendritic cells for their probing, tree-like appendages—did not engage in phagocytosis or adhere to culture surfaces. Instead, they expressed major histocompatibility complex II molecules, effectively functioning as the essential link for activating T cell-mediated immunity.
Mechanisms of Immune Activation
Steinman determined that dendritic cells function as natural adjuvants, capturing and processing antigens to mobilize lymphocyte responses. He demonstrated that these cells exist in immature states until prompted by environmental stimuli, such as microbial products, to mature. Once mature, they communicate with lymphocytes to determine the specific quality of the immune response, including the induction of helper, cytotoxic, and regulatory T cells.
Nobel Recognition and Posthumous Legacy
In 2011, the Nobel Committee awarded Steinman one half of the Nobel Prize in Physiology or Medicine for his work on dendritic cells. The announcement occurred on October 3, 2011, three days after his death in Manhattan due to pancreatic cancer. Because the Nobel Foundation generally forbids posthumous awards, the committee held a special deliberation and concluded that the prize would stand, as the decision had been made in good faith without knowledge of his passing.
Fast facts
- Born: 1943, Montreal
- Died: 2011, Manhattan
- Field: Immunology
- Nobel Prize in Physiology or Medicine: 2011
- Education: McGill University, Harvard Medical School, The Rockefeller University
- Primary discovery: Dendritic cells
Questions readers ask
Why was the Nobel Prize awarded posthumously to Ralph Steinman?
Although the Nobel Foundation rules typically forbid posthumous awards, the Nobel Committee kept the prize unchanged because the decision to honor his discovery of dendritic cells was made in good faith before he died.
What is the primary function of the dendritic cells Steinman discovered?
Dendritic cells act as a bridge between innate and adaptive immunity by capturing and presenting antigens to lymphocytes, effectively initiating the body's adaptive T cell-mediated immune response.